title: Pathology of testicular germ cell tumors.
abstract: The pathology report on a testicular germ cell tumor should include the following information: Tumor type: The histologic type of tumor present. If the tumor is of mixed type, the components should be listed, in order of relative abundance. The pathologist may endeavor to give a numeric estimate of the percentages of each element. Staging information: The size of the tumor should be listed. Local spread--into rete testis, tunica albuginea, epididymis, and spermatic cord--should be listed. If the cord is involved, possible involvement of its surgical resection margin should be assessed. Vascular/lymphatic invasion should be assessed for its presence or absence. Status of the remainder of the testis: Evidence of cryptorchidism or other dysgenetic features should be mentioned. Such features may imply a greater risk for the development of a contralateral tumor. Also, the presence of normal spermatogenesis elsewhere in the uninvolved testis should be reported. This finding may suggest a relatively decreased risk for contralateral tumor development and is a likely indicator of fertility should the patient consider sperm banking prior to retroperitoneal surgery and chemotherapy. The finding of mature sperm in the epididymis is an easy way to confirm spermatogenesis in the testis. Incidental findings: Lipomas or hydroceles of the cord, adrenal rests, and adnexal cysts may be found. The pathologist plays a crucial role in the diagnosis of germ cell tumors. In addition to elucidating tumor type, the pathologist is relied upon for precise local staging and for the classification of metastases, all of which have important implications in determining optimal therapy. As the clinical management of germ cell tumors evolves, the pathologist will continue to play a role in defining those features that have a bearing on patient outcome.
authors.affiliation: Department of Pathology, Harvard Community Health Plan, Boston, MA 02215.
authors.forename: G L
authors.initials: GL
authors.lastname: Brodsky
mesh_terms: D000328:Adult; D002648:Child; D002822:Choriocarcinoma / Q000453:epidemiology / Q000473:pathology; D004407:Dysgerminoma / Q000453:epidemiology / Q000473:pathology; D006801:Humans; D015994:Incidence; D008297:Male; D008649:Mesonephroma / Q000453:epidemiology / Q000473:pathology; D008875:Middle Aged; D009373:Neoplasms, Germ Cell and Embryonal / Q000145:classification / Q000453:epidemiology / Q000473:pathology*; D009378:Neoplasms, Multiple Primary / Q000453:epidemiology; D013724:Teratoma / Q000453:epidemiology / Q000473:pathology; D013736:Testicular Neoplasms / Q000145:classification / Q000453:epidemiology / Q000473:pathology*